Stem Cell Therapy for Autoimmune Diseases

Over 50 million Americans are suffering from autoimmune diseases each and every day. To put that into perspective, that’s 20% of the population. For many, the complications associated with the disease can be debilitating. In the past, suppressive therapy has been used to treat these diseases using steroids to try and control the immune response in the body. Today, we are helping patients find new solutions using innovative stem cell therapy.


Q: Autoimmune Neuropathy and CIDP

A: Autoimmune neuropathy is a painful peripheral nerve condition that occurs because of autoimmune disease. Peripheral neuropathy often occurs in the hands, feet, and lower legs, and patients with the condition experience pain, sensations of tingling or numbness, and muscle weakness. Patients with neuropathy often experience extreme sensitivity to touch. These symptoms can impact a patient’s ability to walk or do everyday activities. Patients with severe cases of autoimmune neuropathy experience feelings of burning, excessive sweating, paralysis. Some autoimmune neuropathy patients have organ, gland, or body system dysfunction or failure. Traditional treatment for peripheral neuropathy includes treating the underlying disease, plasma exchanges, steroids, and pain relieving medications to help manage the painful symptoms, but do not heal the damaged nerve tissue. Some patients require physical therapy.

Chronic inflammatory demyelinating polyneuropathy, or CIDP, is a nerve disorder that causes inflammation of the peripheral nerves. It also destroys the myelin sheath, the protective covering of the nerves, and ultimately leads to damage and loss of nerve tissue. CIDP impacts how the brain and the body communicate, and leads to weakness, loss of motor function, and paralysis. Severity of symptoms varies from patient to patient. Standard treatments for CIDP include steroids and immunosuppressant drugs, intravenous globulin, and plasma exchanges.

For patients with autoimmune neuropathy and CIDP, Innovations Stem Cell Center deploys SVF stem cells through IV along with injections. Damaged tissue attracts stem cells through growth factor chemical messages, and deployed stem cells find the damaged or diseased tissue and begin repairs.

Patients begin seeing results in the first few weeks of treatment. Some patients may require additional deployment.

Q: Myasthenia Gravis

A: Myasthenia gravis is an autoimmune disease that causes weakness in the skeletal muscles. The skeletal muscles are what allows the body to move, breathe, make facial expressions, talk, or swallow. Signs of myasthenia gravis include muscle weakness that occurs after activity, drooping eyelid, or drooping mouth. Other effects of the disease include difficulty breathing or speaking, impaired vision, and difficulty walking. Treatments for myasthenia gravis manage symptoms, but do not cure the disease. Treatments include medications, blood transfusions, steroids, and in severe cases, surgery to remove the thymus gland.

For patients with myasthenia gravis, Innovations Stem Cell Center deploys SVF stem cells through IV along with injections. Damaged tissue attracts stem cells through growth factor chemical messages, and deployed stem cells find the damaged or diseased tissue and begin repairs.

Patients begin seeing results in the first few weeks of treatment. Some patients may require additional deployment.

Q: Autoimmune Hepatitis

A: Autoimmune hepatitis is an autoimmune disorder in which the immune system attacks the liver. The disease causes inflammation, and can lead to cirrhosis of the liver or liver failure. Symptoms of autoimmune hepatitis include fatigue, joint pain, yellowing of the skin, nausea, vomiting, and abdominal pain. Some autoimmune hepatitis patients are swelling of the liver, weight loss, and mental confusion or disorientation. Patients with autoimmune hepatitis are treated with steroids to reduce inflammation of the liver, but long-term use of steroids can cause complications like high blood pressure, weight gain, glaucoma, and lower the immune system’s ability to fight off infection.

For patients with autoimmune hepatitis, Innovations Stem Cell Center deploys SVF stem cells through IV along with injections. Damaged tissue attracts stem cells through growth factor chemical messages, and deployed stem cells find the damaged or diseased tissue and begin repairs.

Patients begin seeing results in the first few weeks of treatment. Some patients may require additional deployment.

Q: Relapsing Polychondritis

A: Relapsing polychondritis is a rare autoimmune disorder of the cartilage that causes recurring inflammation throughout the cartilage in the body. The disorder can affect anywhere there is cartilage in the body, included the joints, nose and ears. The trachea can also be affected. Other tissues, like the eyes, heart, and blood vessels, have a structure like that of cartilage can also be affected by the disorder. Symptoms of the condition include a sudden onset of pain, redness, swelling, and stiffness. Some patients with relapsing polychondritis experience deformity in their tissues, as well as impairment to hearing and balance, along with fever, nausea, and vomiting. Relapsing polychondritis in the trachea can cause difficulty breathing. If the condition affects the eyes, vision lost can result. Patients with polychondritis inflammation of the heart can experience damage to the aorta, leaving them at risk for aneurysm

For patients with relapsing polychondritis, Innovations Stem Cell Center deploys SVF stem cells through IV along with injections. Damaged tissue attracts stem cells through growth factor chemical messages, and deployed stem cells find the damaged or diseased tissue and begin repairs.

Patients begin seeing results in the first few weeks of treatment. Some patients may require additional deployment.

Our Autoimmune Disease Treatments

At Innovations Medical, we treat the following autoimmune ailments with stem cell therapy: